The Orienting Study
Recruiting now
Conditions studied: CPPD - Calcium Pyrophosphate Deposition Disease, Gout
In brief
This study at IRCCS Galeazzi - Sant'Ambrogio Hospital involves patients with gout, CPPD, and osteoarthritis as a control group. Patients will receive routine care with regular clinical, laboratory, and imaging assessments every six months, alongside urgent visits as needed. The study aims to understand crystal deposits in joints and blood vessels and monitor their progression over time, assessing how these deposits respond to standard treatments and if they are associated with cardiovascular complications. Data will be collected from medical records over a follow-up period of up to 10 years, offering long-term insights into disease impact and treatment effectiveness.
Key facts
- Study ID
- NCT07504146
- Run by
- I.R.C.C.S Ospedale Galeazzi-Sant'Ambrogio
- People needed
- 450
- Starts
- 2024-10-30
- Expected to finish
- 2039-10-30
- Last updated by the study team
- 2026-03-31
Who can join
Age: 18 and older. Sex: any. Healthy volunteers: not accepted.
Where it is running
- IRCCS Ospedale Galeazzi-Sant'Ambrogio — Milan, Milano, Italy (enrolling)
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.